Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
95
days
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors
Authors
Stephen C. Harris; Alessandra Cipriano; Garth T. Whiteside; Kerri A. Schoedel; Ellie He; Manjunath S. Shet; Glen ApseloffShow moreShow less
Affiliations
1. Imbrium Therapeutics L.P., Stamford, CT; 2. Altreos Research Partners Inc., Toronto, Canada; 3. Ohio Clinical Trials Inc., Columbus, OHShow moreShow less
105
days
Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia
Authors
Yuki Mukai; James Kost; Linda Snow-adami; Jessica Reed; Theresa Taylor; Justine Kent; Michael F. EganShow moreShow less
Affiliations
1. Merck & Co., Inc., Rahway, NJShow moreShow less
108
days
Effects of Adjunctive Brexpiprazole in Major Depressive Disorder Analyzed by Baseline Anxiety Level
Authors
François Therrien; Caroline Ward; Zhen Zhang; Pratap Chokka; Jeffrey Habert; Zahinoor Ismail; Roger S. McIntyre; A. Marilise MarracheShow moreShow less
Affiliations
1. Otsuka Canada Pharmaceutical Inc., Saint-Laurent, Canada; 2. Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 3. Chokka Center for Integrative Health, Edmonton, Canada; 4. Department of Psychiatry, University of Alberta, Edmonton, Canada; 5. Department of Family and Community Medicine, University of Toronto, Toronto, Canada; 6. Departments of Psychiatry, Clinical Neurosciences, and Community Health Sciences, Hotchkiss Brain Institute and O’Brien Institute for Public Health, University of Calgary, Calgary, Canada; 7. Faculty of Health and Life Sciences, NIHR Exeter Biomedical Research Unit, University of Exeter, Exeter, United Kingdom; 8. Department of Psychiatry, University of Toronto, Toronto, Canada; 9. Lundbeck Canada Inc., Saint-Laurent, CanadaShow moreShow less
121
days
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder
Authors
Lori L. Davis; Saloni Behl; Daniel Lee; Hui Zeng; Taisa Skubiak; Shelley Weaver; Nanco Hefting; Klaus Groes Larsen; Mary HobartShow moreShow less
Affiliations
1. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL; 2. Clinical Development, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 3. Biostatistics, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 4. Clinical Management, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 5. Clinical Development, H. Lundbeck A/S, Valby, Denmark; 6. Biostatistics, H. Lundbeck A/S, Valby, Denmark; 7. R&D Evidence, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJShow moreShow less
116
days
Gender Differences in Psychotropic Medication Use
Authors
Edith J. Liemburg; Klaas J. Wardenaar; Sanne Krol; Maaike M. van Veen; Bennard Doornbos; Arne Risselada; Danielle C. CathShow moreShow less
Affiliations
1. GGZ Friesland, Department of Research, Leeuwarden; 2. Department of Psychiatry, Rob Giel Research Center, University of Groningen, University Medical Center Groningen; 3. Department of Child and Family Welfare, Faculty of Behavioural and Social Sciences, University of Groningen, Groningen; 4. GGZ Drenthe Mental Health Services, Assen, The Netherlands; 5. Lentis Mental Health Organization, Lentis Research, Groningen; 6. Department of Clinical Pharmacy, Wilhelmina Hospital, Assen, The NetherlandsShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days